Your browser doesn't support javascript.
loading
Hydrocortisone, ascorbic acid and thiamine for sepsis: Is the jury out?
Marik, Paul Ellis; Varon, Joseph; Surani, Salim R.
Afiliação
  • Marik PE; Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, United States. marikpe@evms.edu.
  • Varon J; Department of Critical Care, United Memorial Medical Service, Houston, TX 77030, United States.
  • Surani SR; Texas A and M University, Corpus Christi, TX 78413, United States.
World J Diabetes ; 11(4): 90-94, 2020 Apr 15.
Article em En | MEDLINE | ID: mdl-32313607
ABSTRACT
Sepsis and septic shock remain a major cause of morbidity and mortality among patients admitted in the intensive care unit. Diabetes is a major risk factor for the development of sepsis. The global mortality of sepsis remains high, despite significant interventions and guidelines. It has been known for decades that patients with sepsis have reduced levels of antioxidants, most notably vitamin C. Furthermore, experimental data has demonstrated multiple beneficial effects of vitamin C in sepsis. In addition, corticosteroids and thiamine may have synergistic biological effects together with vitamin C. Preliminary data suggests that therapy with hydrocortisone, ascorbic acid and thiamine improves the outcome of patients with sepsis with the potential to save millions of lives. However, this intervention has met with much resistance and has not been widely adopted. Ultimately, we await the final jury verdict on this simple, safe and cheap intervention.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article